Safety, Reactogenicity, and Immunogenicity of a 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Adult Pregnant Women: Study Protocol for a Phase 3 Open-Label Randomized Controlled Trial
Trials(2022)
Key words
Ebola virus,Vaccine safety,Reactogenicity,Immunogenicity,Pregnancy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined